|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Impairment of long-lived assets | |||||
| Impairment of goodwill | |||||
| Gain on sale of intangible assets | |||||
| Gain on sale of subsidiary | |||||
| Selling, general and administrative expenses | |||||
| Income (loss) from operations | |||||
| Interest expense, net | |||||
| Other income | |||||
| Income (loss) before income taxes and equity in net income of equity method investment | |||||
| Provision (benefit) for income taxes | |||||
| Income (loss) before equity in net income of equity method investment | |||||
| Equity in net income of equity method investment | |||||
| Net income (loss) | |||||
| Other comprehensive income: | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive income (loss) | |||||
| Earnings (loss) per share: | |||||
| Basic earnings (loss) per share | |||||
| Diluted earnings (loss) per share | |||||
| Weighted average shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...
